Physeal Abnormalities in Children With High-risk Neuroblastoma Intensively Treated With/Without 13-Cis-Retinoic Acid.

Abstract

BACKGROUND:

This study aimed to investigate the presence of physeal abnormality and its effect on growth in children with high-risk neuroblastoma treated by intensive multimodal treatment with/without 13-cis-retinoic acid (13-CRA).

METHODS:

Fifteen patients diagnosed with high-risk neuroblastomas at the age of 1 to 10 years, who received treatment such as high-dose chemotherapy and autologous stem cell transplantation with/without 13-CRA, and with complete data during their >2-year follow-up were retrospectively reviewed. The physeal abnormalities were investigated by whole-body magnetic resonance imaging, serially performed every 3 to 6 months. The patients' height growth was also investigated and compared with that of age-and-sex-matched patients with brain tumors who also underwent high-dose chemotherapy and autologous stem cell transplantation.

RESULTS:

Six of 15 patients presented multifocal physeal abnormalities during follow-up, and all lesions occurred in patients with 13-CRA use. The lesions in 3 patients completely resolved spontaneously without any adverse effect on growth, but some lesions in the other 3 patients progressed to disturb the bony growth. Height growth of matched patients with brain tumors were not significantly different, and none of the matched controls showed definite bony deformity during the follow-up.

CONCLUSIONS:

Some children who were treated for high-risk neuroblastomas experienced multifocal physeal insults, probably due to the use of 13-CRA. Most lesions resolved spontaneously, but some led to bony deformity. If the lesions are not followed by premature physeal closure, there seems to be no further adverse effect of 13-CRA on leg length growth. Routine periodic screening for physeal status is needed for the patients with high-risk neuroblastomas using 13-CRA.

LEVEL OF EVIDENCE:

Level IV-prognostic study.

• Authors: Kyung-Nam Koh, Ji Young Jeon, Soo-Sung Park, Ho Joon Im, Hyery Kim, Michael Seungcheol Kang
• Journal: Journal of pediatric orthopedics (J Pediatr Orthop) Vol. 41 Issue 9 Pg. e841-e848 (Oct 01 2021) ISSN: 1539-2570 [Electronic] United States
• PMID: 34387230 (Publication Type: Journal Article)
• Copyright: Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Chemical References

• Isotretinoin

Topics

• Child
• Child, Preschool
• Hematopoietic Stem Cell Transplantation
• Humans
• Infant
• Isotretinoin (adverse effects)
• Magnetic Resonance Imaging
• Neuroblastoma (diagnostic imaging, drug therapy)
• Retrospective Studies
• Transplantation, Autologous
• Whole Body Imaging